Low neutrophil counts, a condition doctors call neutropenia, can stem from dozens of causes spanning viral infections, medications, autoimmune diseases, nutritional gaps, inherited genetic mutations, and bone marrow disorders. Neutrophils are the most abundant white blood cells in your bloodstream and your front line against bacterial and fungal invaders. Because your body produces and destroys them at a staggering rate, anything that disrupts their production, accelerates their destruction, or traps them outside the bloodstream can tip the balance. The result is a measurable drop on a routine blood test that sometimes signals a temporary, harmless dip and other times points to something that demands immediate attention.
Why Neutrophils Are Uniquely Vulnerable to Supply Disruptions
Your bone marrow churns out roughly 50 to 100 billion neutrophils every day just to keep pace with normal turnover. Once they enter the blood, neutrophils circulate for less than a day before migrating into tissues or being cleared by the liver and spleen.1Trends in Immunology. Neutrophil Diversity in Health and Disease Their circulating half-life is only about six to eight hours.2PubMed Central. Neutrophil kinetics in health and disease That astonishingly short lifespan means the bone marrow has almost no margin for error. A few days of impaired production or a burst of extra destruction can empty the tank far faster than it would for red blood cells, which survive for months.
Not all neutrophils in your body are even circulating freely. A substantial proportion exists in a “marginated” pool, meaning they are slowly transiting through capillary beds and organ tissues rather than flowing through large blood vessels.2PubMed Central. Neutrophil kinetics in health and disease A standard blood draw only measures the freely circulating pool, so shifts between these compartments can make neutrophil counts fluctuate even when total body numbers haven’t changed much. This partly explains why a single low reading on a blood test doesn’t always mean trouble.
How Infections Drive Down Neutrophil Counts
It sounds paradoxical: infections are the very thing neutrophils exist to fight, yet infections are one of the most common reasons neutrophil counts drop. The mechanisms depend on the type of pathogen involved.
Viral Infections
Many common viruses can temporarily suppress the bone marrow’s ability to produce neutrophils or directly damage existing ones. Influenza, HIV, Epstein-Barr virus, hepatitis B and C, and parvovirus B19 are well-known culprits. The neutropenia in most routine viral illnesses is mild and self-limiting, resolving as the infection clears. In HIV, however, the effect can be chronic and compounded by the medications used to treat the virus itself.
Overwhelming Bacterial Infection and Sepsis
In severe bacterial infections, neutrophils are consumed faster than the marrow can replace them. When bacteria flood the bloodstream, huge numbers of neutrophils rush out of circulation into infected tissues. One way they fight is through a dramatic self-destruct mechanism in which they release web-like structures of DNA and antimicrobial proteins to trap and kill bacteria. In severe sepsis, so many neutrophils are consumed through this process that blood counts plummet.3PubMed Central. A Case of Severe Sepsis Presenting Marked Decrease of Neutrophils and Interesting Findings on Dynamic CT At the same time, surviving neutrophils become stiffer and stickier, getting trapped in the capillary beds of the lungs and liver rather than flowing freely.4PubMed Central. Neutrophil dysregulation during sepsis: an overview and update The combination of mass consumption and sequestration can produce alarmingly low counts at the very moment you most need those cells.
Medications That Suppress Neutrophil Production
Chemotherapy
Cancer chemotherapy is probably the most predictable cause of neutropenia. The drugs target rapidly dividing cells, and because bone marrow progenitor cells divide constantly to meet that enormous daily demand, they get caught in the crossfire. After a typical chemotherapy cycle, neutrophil counts drop to their lowest point, called the nadir, roughly nine to seventeen days after dosing, depending on the drug regimen.5PubMed Central. Predicting chemotherapy-induced neutropenia and granulocyte-colony stimulating factor response using model-based in vitro to clinical translation In aggressive induction chemotherapy for acute leukemia, the median nadir can be extremely deep, sometimes dropping below 100 cells per microliter.6PubMed Central. Peripheral Blood Neutrophil Nadir and Time to Platelet Recovery during Induction Chemotherapy Recovery usually begins within weeks as the marrow rebuilds, but repeated cycles can make each recovery slower.
Idiosyncratic Drug Reactions
Unlike chemotherapy, where neutropenia is an expected side effect, some medications cause sudden, severe drops in an unpredictable way. Clozapine, an antipsychotic, is perhaps the most well-known example and requires mandatory blood count monitoring for every patient who takes it. Research shows that clozapine gets converted into a reactive chemical intermediate that can damage the supportive stromal cells in the bone marrow that neutrophils depend on during development.7PubMed. Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells
Other drugs associated with this kind of reaction include certain anti-thyroid medications (methimazole, propylthiouracil), some antibiotics (trimethoprim-sulfamethoxazole), and anti-seizure drugs. The underlying mechanism appears to be immune-mediated: the drug or its metabolite triggers an immune response that destroys neutrophils or their precursors. Genetic studies have linked the risk to specific immune-system genes, including those that code for the proteins responsible for presenting foreign substances to the immune system.8PubMed. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis Because these reactions are rare and genetically influenced, there is no reliable way to predict them in most cases beyond known high-risk drugs like clozapine.
Radiation Exposure
Ionizing radiation damages the bone marrow’s stem cells, the parent cells that eventually mature into neutrophils and all other blood cells. Therapeutic radiation to large areas of bone (as in some cancer treatments) or accidental radiation exposure can cause acute neutropenia. The marrow’s micro-environment is also disrupted, which slows recovery even after the radiation stops.9PubMed Central. Insights into ionizing radiation-induced bone marrow hematopoietic stem cell injury
Autoimmune Causes
Your immune system can sometimes turn against your own neutrophils. In autoimmune neutropenia, antibodies latch onto proteins on the neutrophil surface and mark them for destruction. Most of these antibodies target a receptor called FcγRIIIb, though other surface proteins can be involved as well.10PubMed Central. Primary and secondary autoimmune neutropenia The condition comes in two forms. Primary autoimmune neutropenia is most common in infants and toddlers and typically resolves on its own within a year or two. Secondary autoimmune neutropenia occurs alongside other autoimmune or lymphoproliferative conditions and tends to be more persistent.11PubMed. Autoimmune neutropenia
A specific syndrome worth knowing about is Felty syndrome, which occurs in people with long-standing rheumatoid arthritis. In Felty syndrome, both the cellular and antibody arms of the immune system contribute to neutrophil destruction. Inflammatory cytokines suppress the marrow’s ability to produce new neutrophils, and antibodies bind to neutrophil DNA traps, accelerating their death. The spleen also enlarges and sequesters neutrophils, compounding the problem.12PubMed Central. Felty’s Syndrome, Insights and Updates Felty syndrome is uncommon today because earlier and more aggressive treatment of rheumatoid arthritis with modern immunosuppressive drugs seems to prevent it from developing in many patients.
Nutritional Deficiencies That Quietly Erode Neutrophil Counts
The bone marrow requires a steady supply of certain vitamins and minerals to produce blood cells. When those supplies run short, neutrophil production can stall.
Severe vitamin B12 deficiency is one of the most dramatic examples. Because B12 is essential for DNA synthesis, a deficiency impairs the rapid cell division that blood cell production requires. The result can be a broad collapse of blood cell numbers affecting not only neutrophils but also red blood cells and platelets. The changes in the marrow can be so striking that they mimic leukemia on a biopsy, sometimes prompting aggressive workups before the real culprit is identified.13PubMed Central. Vitamin B12 deficiency mimicking acute leukemia Folate deficiency produces a similar picture for the same reasons.
Copper deficiency is a sneakier cause. Copper is needed for enzymes that protect neutrophils from oxidative damage and support iron metabolism. When copper levels fall, neutrophil survival drops because critical protective enzymes inside the cells stop working properly.14PubMed. Discovering the hidden link: hematological disorders caused by copper deficiency One surprisingly common route to copper deficiency is excessive zinc supplementation, because zinc and copper compete for absorption in the gut. Overuse of zinc supplements or zinc-containing denture adhesives has led to cases severe enough to produce both anemia and neutropenia that mimic bone marrow cancer.15PubMed Central. A Hematologic Twist: Zinc-Induced Copper Deficiency Mimicking Myelodysplastic Syndrome The fix is straightforward once the cause is found: stop the excess zinc and replace copper.
Inherited and Genetic Forms of Neutropenia
Some people are born with genetic mutations that permanently affect neutrophil production. The two main inherited forms are severe congenital neutropenia and cyclic neutropenia, and both are most commonly caused by mutations in a gene called ELANE, which provides the blueprint for an enzyme packed inside neutrophils.16PubMed Central. ELANE mutations in cyclic and severe congenital neutropenia
In severe congenital neutropenia, the mutant enzyme causes developing neutrophils to self-destruct before they mature. Neutrophil production stalls at an early stage in the bone marrow, and counts remain dangerously low from birth.17PubMed Central. Severe congenital neutropenia caused by ELANE gene mutation Children with this condition face recurrent serious infections unless treated, and they also carry a long-term risk of developing leukemia.
Cyclic neutropenia is less severe but more unusual in its pattern. Neutrophil counts oscillate on an approximately 21-day cycle, swinging from normal levels down to near zero and back again.16PubMed Central. ELANE mutations in cyclic and severe congenital neutropenia During the low phase, which typically lasts three to five days, the person is vulnerable to mouth sores, fevers, and infections. Interestingly, as the neutrophil count drops, monocyte numbers rise to partially compensate, and the rate at which monocytes turn over can more than double compared to the recovery phase.18Blood. Neutrophil and Monocyte Kinetics in a Case of Cyclic Neutropenia The body appears to partially compensate with another branch of the immune system when neutrophils are scarce.
Benign Ethnic Neutropenia and the Duffy Antigen
Not every low neutrophil count signals disease. Many people of African, Middle Eastern, or certain other ancestries carry a genetic variant that results in constitutionally lower neutrophil counts compared to the reference ranges derived primarily from European populations. This variant sits in the promoter region of the ACKR1 gene (formerly known as the Duffy antigen gene) and disrupts the expression of a chemokine receptor on red blood cells. A specific single nucleotide change in this gene was found to predict lower white blood cell and neutrophil counts in African Americans and Yemenite Jews.19PubMed. The Duffy antigen receptor for chemokines, ACKR1,- ‘Jeanne DARC’ of benign neutropenia
People with this variant are healthy and do not face increased infection risk despite having counts that would technically qualify as neutropenic by standard laboratory cutoffs. The practical problem is that clinicians unfamiliar with benign ethnic neutropenia may launch unnecessary workups or delay needed treatments like chemotherapy based on counts that are actually normal for that individual. Recognition of this variant has led to calls for population-adjusted reference ranges, but adoption has been uneven.
Bone Marrow Disorders and Splenic Trapping
Diseases that directly invade or damage the bone marrow can crowd out or destroy the precursor cells that eventually become neutrophils. Myelodysplastic syndromes are a group of conditions in which the marrow produces blood cells that are abnormal in shape and function. In these patients, neutropenia correlates with more severe marrow failure and a higher percentage of abnormal blast cells, marking more advanced disease.20PubMed Central. Neutropenia (even mild) and anemia are poor prognostic factors in myelodysplastic syndromes Leukemias, lymphomas, and metastatic cancers that infiltrate the marrow can produce similar effects.
The spleen plays its own role. When the spleen enlarges, whether from liver disease, blood cancers, or other causes, it can trap a disproportionate share of circulating neutrophils and platelets. Research using epinephrine stimulation (which causes the spleen to contract) has shown that neutrophil counts can jump by an average of about 86% as cells are released from the spleen back into circulation.21Swiss Medical Weekly. Diagnosis of hypersplenism with the epinephrine stimulation test The neutrophils aren’t missing from the body; they’re just parked in the wrong place.
Neonatal Neutropenia
Newborns can develop neutropenia through a mechanism borrowed from transfusion medicine. In neonatal alloimmune neutropenia, antibodies from the mother cross the placenta and attack fetal neutrophils. This happens when the baby inherits neutrophil surface proteins from the father that the mother’s immune system recognizes as foreign, prompting her to produce antibodies against them.22PubMed. Neonatal alloimmune neutropenia attributed to maternal immunoglobulin G antibodies against the neutrophil alloantigen HNA-1c (SH) The condition usually resolves within weeks as the maternal antibodies clear from the baby’s system, but the interim period can carry a risk of serious infections in the newborn.
When Low Counts Become Dangerous
The risk of infection from neutropenia depends heavily on how low the count drops and how long it stays there. A normal neutrophil count for most adults falls between about 1,500 and 7,000 cells per microliter. Counts below 1,500 are classified as neutropenic, below 500 as severely neutropenic, and below 100 as profoundly neutropenic. The infection risk rises sharply once counts fall below 500 and becomes most serious below 100.
Data from pediatric cancer patients illustrate this threshold effect. Children discharged from hospital with post-treatment counts between 100 and 500 per microliter had similar seven-day readmission rates of around 4%, while those sent home with counts below 100 had a readmission rate roughly three times higher.23PubMed Central. Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery The depth and duration of neutropenia together determine the real-world danger: a count of 200 for two days is a very different situation than a count of 50 for three weeks.
How Doctors Investigate and Treat Neutropenia
The diagnostic workup starts with a complete blood count and a careful look at the blood smear under a microscope. The smear can reveal abnormal cell shapes, immature cells that shouldn’t be circulating, or signs that point toward specific marrow problems.24PubMed Central. Diagnosis and management of neutropenia Basic blood chemistry, liver and kidney function tests, and screening for common infections help narrow the field. If the cause remains unclear, a bone marrow biopsy is the next step to look for infiltrating cancers, dysplastic changes, or maturation arrest.25Blood. How we evaluate and treat neutropenia in adults
Treatment depends entirely on the cause. Neutropenia from a medication usually resolves when the drug is stopped. Nutritional deficiencies respond to replacement. Autoimmune forms may need immunosuppressive therapy. For situations where neutropenia is severe and poses an immediate infection risk, particularly during chemotherapy, doctors often turn to growth factor injections. G-CSF (filgrastim) and its longer-acting pegylated form are FDA-approved for both congenital and acquired neutropenias and work by stimulating the bone marrow to ramp up neutrophil production.26PubMed Central. G-CSF and GM-CSF in Neutropenia For patients with severe congenital neutropenia who don’t respond adequately to growth factors, bone marrow transplantation remains an option, though it carries its own substantial risks.
Pseudoneutropenia and Other Measurement Artifacts
Sometimes neutrophils look low on paper but aren’t actually depleted. Because the standard blood test measures only the freely flowing pool, anything that temporarily shifts neutrophils into the marginated compartment along vessel walls and capillary beds can produce a reading that underestimates the real supply. Exercise, stress, and even the time of day can push counts in either direction, since cortisol and adrenaline both influence how neutrophils distribute between pools. Morning counts tend to be lower than afternoon counts in the same person.
Repeated borderline-low readings in someone who feels perfectly healthy, has no infections, and belongs to an ancestry group with known lower baseline counts should prompt a conversation about benign ethnic neutropenia or chronic idiopathic neutropenia rather than an escalating cascade of invasive tests. The worst outcome isn’t a low number on a lab report; it’s a healthy person subjected to a bone marrow biopsy they never needed because a single result was interpreted without context.